EVOLUTION OF HIGH-DOSE CISPLATIN

被引：0
|
作者：
HOLLERAN, WM
DEGREGORIO, MW
机构：
[1] YALE UNIV,SCH MED,DEPT INTERNAL MED,MED ONCOL SECT,POB 3333,333 CEDAR ST,NEW HAVEN,CT 06510
[2] PACIFIC PRESBYTERIAN MED CTR,CHILDRENS CANC RES INST,CANC PHARMACOL & PHARMACOKINET LAB,SAN FRANCISCO,CA 94115
来源：
INVESTIGATIONAL NEW DRUGS | 1988年 / 6卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：135 / 142
页数：8
相关论文
共 50 条
  • [21] HIGH-DOSE CISPLATIN-RELATED PERIPHERAL NEUROPATHY
    OSTCHEGA, Y
    DONOHUE, M
    FOX, N
    CANCER NURSING, 1988, 11 (01) : 23 - 32
  • [22] Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics
    PJ Cagnoni
    S Matthes
    TC Day
    SI Bearman
    EJ Shpall
    RB Jones
    Bone Marrow Transplantation, 1999, 24 : 1 - 4
  • [23] HIGH-DOSE CISPLATIN AND DECARBAZINE IN THE TREATMENT OF METASTATIC MELANOMA
    LUGER, SM
    KIRKWOOD, JM
    ERNSTOFF, MS
    VLOCK, DR
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (24) : 1934 - 1937
  • [24] Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics
    Cagnoni, PJ
    Matthes, S
    Day, TC
    Bearman, SI
    Shpall, EJ
    Jones, RB
    BONE MARROW TRANSPLANTATION, 1999, 24 (01) : 1 - 4
  • [25] ENDODERMAL SINUS TUMOR TREATED WITH HIGH-DOSE CISPLATIN
    VONEYBEN, FE
    SIDDIQUI, MZ
    THUNOLD, S
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1989, 68 (07) : 669 - 670
  • [26] CLINICAL-PHARMACOLOGY OF HIGH-DOSE CISPLATIN - REPLY
    COLLINS, JM
    CORDEN, BJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 15 (02) : 183 - 184
  • [27] HIGH-DOSE CISPLATIN AND ETOPOSIDE IN ADVANCED MALIGNANCIES OF CHILDHOOD
    PERIN, G
    DALLORSO, S
    STURA, M
    MORONI, C
    ROGERS, D
    DINI, G
    DEBERNARDI, B
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1987, 4 (04) : 329 - 336
  • [28] High-Dose Cisplatin for Head and Neck Cancer Lives On
    Thai, Alesha A.
    Rischin, Danny
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (11) : 1055 - 1057
  • [29] A PHASE-II TRIAL OF HIGH-DOSE CISPLATIN AND DACARBAZINE - LACK OF EFFICACY OF HIGH-DOSE, CISPLATIN-BASED THERAPY FOR METASTATIC MELANOMA
    STEFFENS, TA
    BAJORIN, DF
    CHAPMAN, PB
    LOVETT, DR
    CODYJOHNSON, BV
    TEMPLETON, MA
    HEELAN, RT
    WONG, GY
    PORTLOCK, CS
    OETTGEN, HF
    HOUGHTON, AN
    CANCER, 1991, 68 (06) : 1230 - 1237
  • [30] THE BENEFIT AND RISK OF HIGH-DOSE METOCLOPRAMIDE IN COMPARISON TO HIGH-DOSE HALOPERIDOL OR TRIFLUPROMAZINE IN CISPLATIN-INDUCED EMESIS
    SALLER, R
    HELLENBRECHT, D
    KLINISCHE WOCHENSCHRIFT, 1985, 63 (09): : 428 - 432
12345